Ethyl 2-(2-Piperidyl)acetate

Catalog No.: 
ACVAHF530
CAS No.: 
2739-99-3
Molecular Formula: 
C9H17NO2
Molecular Weight: 
171.24
Ethyl 2-(2-Piperidyl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$92.00In stockInquiry
5g98%$258.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2-Piperidyl)acetate
IUPAC Nameethyl 2-(piperidin-2-yl)acetate
MDL No.MFCD09752674
Molecular FormulaC9H17NO2
Molecular Weight171.24
SMILESO=C(OCC)CC1NCCCC1
InChI KeySEJLPOWVAACXJQ-UHFFFAOYSA-N
SynonymETHYL 2-PIPERIDINEACETATE;ETHYL PIPERIDIN-2-YLACETATE;PIPERIDIN-2-YL-ACETIC ACID ETHYL ESTER;Ethyl 2-(2-Piperidyl)acetate;Ethyl 2-(piperidin-2-yl);ethyl piperidin-2-ylacetate(SALTDATA: FREE);ethyl 2-(piperidin-2-yl)acetate;2-Piperidineacetic acid, ethyl ester
CAS No.2739-99-3

Safety Data

Pictogram
Health hazard
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACVAHF530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDCKY593 route compound structure diagram
    ACDCKY5932739-98-2In Stock
  2. Then
  3. ACVAHF530 route product structure diagram
    ACVAHF5302739-99-3In Stock
Inquiry

2. ACVAHF530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDCKY593 route compound structure diagram
    ACDCKY5932739-98-2In Stock
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACVAHF530 route product structure diagram
    ACVAHF5302739-99-3In Stock
Inquiry

3. ACVAHF530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVAHF530 route product structure diagram
    ACVAHF5302739-99-3In Stock
Inquiry

Comments (0)